A股異動丨隆基股份跌4.63% 第三季度業績不及預期
格隆匯10月18日丨隆基股份(601012.SH)本週三大跌8.6%,昨日稍有企穩後今日再度下跌4.63%,報23.08元,成交17億元,總市值870.7億元。隆基股份本週二盤後公佈,預計2019年前三季度實現歸屬於上市公司股東的淨利潤為34.02億元-35.02億元,同比增加101%-107%;其中,第三季度歸屬於上市公司股東的淨利潤為13.92億元-14.92億元,同比增加263%-289%。近期有賣方機構推薦買入隆基股份,主要邏輯是業績超預期,其中第三季度淨利潤或高達17億元,但在業績預告公佈後,預告上限尚不足15億元,導致套利資金紛紛出逃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.